Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016, Article ID 5042604, 7 pages
http://dx.doi.org/10.1155/2016/5042604
Research Article

A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson’s Disease in Isparta, Turkey

1Department of Medical Biology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey
2Department of Neurology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey
3Department of Biochemistry, Faculty of Science, Süleyman Demirel University, Isparta, Turkey

Received 14 August 2016; Revised 10 November 2016; Accepted 21 November 2016

Academic Editor: Jan Aasly

Copyright © 2016 Nilufer Sahin-Calapoglu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Calne, “A definition of Parkinson's disease,” Parkinsonism and Related Disorders, vol. 11, no. 1, pp. S39–S40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Lester and E. Otero-Siliceo, “Parkinson's disease and genetics,” The Neurologist, vol. 12, no. 5, pp. 240–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. E. C. Hirsch and S. Hunot, “Neuroinflammation in Parkinson's disease: a target for neuroprotection?” The Lancet Neurology, vol. 8, no. 4, pp. 382–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. G. Tansey, M. K. McCoy, and T. C. Frank-Cannon, “Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention,” Experimental Neurology, vol. 208, no. 1, pp. 1–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Nagatsu and M. Sawada, “Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines,” Cellular and molecular neurobiology, vol. 26, no. 4-6, pp. 781–802, 2006. View at Google Scholar · View at Scopus
  6. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, “Mechanisms underlying inflammation in neurodegeneration,” Cell, vol. 140, no. 6, pp. 918–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Sinha, N. Ghosh, S. Mitra et al., “Neuroinflammation during Parkinson's disease: key cells and molecules involved in it,” in Inflammation: the Common Link in Brain Pathologies, pp. 185–208, Springer, Berlin, Germany, 2016. View at Publisher · View at Google Scholar
  8. E. C. Hirsch, T. Breidert, E. Rousselet, S. Hunot, A. Hartmann, and P. P. Michel, “The role of glial reaction and inflammation in Parkinson's disease,” Annals of the New York Academy of Sciences, vol. 991, pp. 214–228, 2003. View at Google Scholar · View at Scopus
  9. S. H. Mehta and C. M. Tanner, “Role of neuroinflammation in parkinson disease: the enigma continues,” Mayo Clinic Proceedings, vol. 91, no. 10, pp. 1328–1330, 2016. View at Publisher · View at Google Scholar
  10. A. De Virgilio, A. Greco, G. Fabbrini et al., “Parkinson's disease: autoimmunity and neuroinflammation,” Autoimmunity Reviews, vol. 15, no. 10, pp. 1005–1011, 2016. View at Publisher · View at Google Scholar
  11. M. Çağlar and E. Kansu, “Kemokinler, kemokin reseptörleri ve inflamasyon,” ANKEM Dergisi, vol. 18, no. 2, pp. 164–168, 2004. View at Google Scholar
  12. W. Wagner, C. Roderburg, F. Wein et al., “Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors,” Stem Cells, vol. 25, no. 10, pp. 2638–2647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Hesselgesser and R. Horuk, “Chemokine and chemokine receptor expression in the central nervous system,” Journal of Neurovirology, vol. 5, no. 1, pp. 13–26, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Qidwai, “Chemokine genetic polymorphism in human health and disease,” Immunology Letters, vol. 176, pp. 128–138, 2016. View at Publisher · View at Google Scholar
  15. J. B. Haldane, “The estimation and significance of the logarithm of a ratio of frequencies,” Annals of Human Genetics, vol. 20, no. 4, pp. 309–311, 1956. View at Publisher · View at Google Scholar · View at Scopus
  16. P. D. Sasieni, “From genotypes to genes: doubling the sample size,” Biometrics, vol. 53, no. 4, pp. 1253–1261, 1997. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  17. M. Maral Mouradian, “Recent advances in the genetics and pathogenesis of Parkinson disease,” Neurology, vol. 58, no. 2, pp. 179–185, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. V. L. Bryant and C. A. Slade, “Chemokines, their receptors and human disease: the good, the bad and the itchy,” Immunology and Cell Biology, vol. 93, no. 4, pp. 364–371, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Huerta, V. Álvarez, I. F. Mata et al., “Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease,” Neuroscience Letters, vol. 370, no. 2-3, pp. 151–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. O. A. Ross, C. O'Neill, I. M. Rea et al., “Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish,” Human Immunology, vol. 65, no. 4, pp. 340–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Nishimura, S. Kuno, I. Mizuta et al., “Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease,” Movement Disorders, vol. 18, no. 8, pp. 953–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Pola, A. Flex, E. Gaetani et al., “Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians,” Experimental Gerontology, vol. 39, no. 8, pp. 1249–1252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Gao, H. Tang, K. Nie et al., “MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort,” Neurological Sciences, vol. 36, no. 4, pp. 571–576, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Schmid, A. Boucherot, Y. Yasuda et al., “Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy,” Diabetes, vol. 55, no. 11, pp. 2993–3003, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Bai, K. Tanaka, T. Tazawa, N. Yamamoto, and H. Sugiura, “Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients,” Journal of Dermatological Science, vol. 39, no. 3, pp. 189–191, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. Elsaadany, I. K. Afifi, and M. Seliem, “RANTES as a predictor for rheumatoid arthritis susceptibility and activity in Egyptians,” Egyptian Rheumatologist, vol. 33, no. 2, pp. 85–91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Rentzos, C. Nikolaou, E. Andreadou et al., “Circulating interleukin-15 and RANTES chemokine in Parkinson's disease,” Acta Neurologica Scandinavica, vol. 116, no. 6, pp. 374–379, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Reale, C. Iarlori, A. Thomas et al., “Peripheral cytokines profile in Parkinson's disease,” Brain, Behavior, and Immunity, vol. 23, no. 1, pp. 55–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Tang, L. Chong, X. Li et al., “Correlation between serum RANTES levels and the severity of Parkinson's disease,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 208408, 4 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Qin, S. Zhang, C. Cao, Y. P. Loh, and Y. Cheng, “Aberrations in peripheral inflammatory cytokine levels in parkinson disease,” JAMA Neurology, vol. 73, no. 11, p. 1316, 2016. View at Publisher · View at Google Scholar